Tweet

This spectacular figure includes the prescribed drugs but also those purchased without prescription. The IMS Health report entitled "Global Outlook for Medicines through 2018" underlines that the growth was 8.8% in 2014 and that this market is expected to increase by 4% to 7% p.a. by 2018. Of course, this growth will be driven mainly by the major emerging countries. It could attain 10.5% p.a. in India. By contrast, spending in Europe will remain limited by a weak economic recovery and a low population growth. This is especially true in France and Spain due to budgetary cuts. The report also highlights that there have been signs of a break in current trends which will radically transform the health sector and more particularly the drug market. To mention just a few examples: the arrival of wireless and mobile technologies or the placing on the market of very expensive drugs. As a result, Authorities around the world will have to accept that the high costs of these new treatment options are likely to put strains on public healthcare budgets.

Mo Tailland / 27th March 2015

Tweet